HIGHLIGHTS
SUMMARY
Drug-induced liver injury (DILI) is an underappreciated adverse drug reaction, in that the diagnosis of it still relies on the causality assessment, and that the Roussel Uclaf Causality Assessment Method (RUCAM) is the most commonly used scale recommended by various liver and Gastrointestinal associations. DILI can mimic features of various liver diseases, such as acute liver failure, druginduced autoimmune hepatitis, and drug-associated fatty liver disease. The dramatic increase in drug-induced acute liver failure, setbacks in anti-tumor treatment, and herbal-related liver injury have raised global public health concerns. Specifically, the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.